Internacional

Costa Rica llama a democratizar la distribución de vacunas contra el covid-19

Mainz (Germany), 11/11/2020.- An undated handout picture made available by the German pharmaceutical company Biontec shows the dosing of BNT162b2, the mRNA-based vaccine candidate against COVID-19, during the clinical test. Pfizer and Biontech SE announced on 11 November 2020 that they have reached an agreement with the European Commission to supply 200 million doses of their investigational BNT162b2 mRNA-based vaccine candidate against COVID-19 to European Union (EU) Member States, with an option for the European Commission to request an additional 100 million doses. (Alemania) EFE/EPA/BIONTECH SE / HANDOUT HANDOUT EDITORIAL USE ONLY/NO SALES

Mainz (Germany), 11/11/2020.- An undated handout picture made available by the German pharmaceutical company Biontec shows the dosing of BNT162b2, the mRNA-based vaccine candidate against COVID-19, during the clinical test. Pfizer and Biontech SE announced on 11 November 2020 that they have reached an agreement with the European Commission to supply 200 million doses of their investigational BNT162b2 mRNA-based vaccine candidate against COVID-19 to European Union (EU) Member States, with an option for the European Commission to request an additional 100 million doses. (Alemania) EFE/EPA/BIONTECH SE / HANDOUT HANDOUT EDITORIAL USE ONLY/NO SALES

Costa Rica llamó este sábado a intensificar la producción de vacunas contra el covid-19 y a democratizar su distribución para cubrir las necesidades de los países más pobres, que enfrentan dificultades de acceder a ellas. “Es un hecho que se requiere un escalamiento de la capacidad de producción, así como la democratización de la distribución de las vacunas”, declaró el canciller costarricense, Rodolfo Solano, en una sesión de ministros del Consejo Económico y Social de la ONU.